These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26070211)

  • 1. Development of a Hamster Model for Chikungunya Virus Infection and Pathogenesis.
    Bosco-Lauth AM; Han S; Hartwig A; Bowen RA
    PLoS One; 2015; 10(6):e0130150. PubMed ID: 26070211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viremia in North American Mammals and Birds After Experimental Infection with Chikungunya Viruses.
    Bosco-Lauth AM; Nemeth NM; Kohler DJ; Bowen RA
    Am J Trop Med Hyg; 2016 Mar; 94(3):504-6. PubMed ID: 26666699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chikungunya virus pathogenesis: From bedside to bench.
    Couderc T; Lecuit M
    Antiviral Res; 2015 Sep; 121():120-31. PubMed ID: 26159730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
    Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular mechanisms of chikungunya pathogenesis.
    Lum FM; Ng LF
    Antiviral Res; 2015 Aug; 120():165-74. PubMed ID: 26092642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An animal model for studying the pathogenesis of chikungunya virus infection.
    Ziegler SA; Lu L; da Rosa AP; Xiao SY; Tesh RB
    Am J Trop Med Hyg; 2008 Jul; 79(1):133-9. PubMed ID: 18606777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
    Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
    mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chikungunya virus: host pathogen interaction.
    Singh SK; Unni SK
    Rev Med Virol; 2011 Mar; 21(2):78-88. PubMed ID: 21412934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.
    Acharya D; Paul AM; Anderson JF; Huang F; Bai F
    PLoS Negl Trop Dis; 2015; 9(10):e0004139. PubMed ID: 26484530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium co-infection protects against chikungunya virus-induced pathologies.
    Teo TH; Lum FM; Ghaffar K; Chan YH; Amrun SN; Tan JJL; Lee CYP; Chua TK; Carissimo G; Lee WWL; Claser C; Rajarethinam R; Rénia L; Ng LFP
    Nat Commun; 2018 Sep; 9(1):3905. PubMed ID: 30254309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated
    Carrau L; Rezelj VV; Noval MG; Levi LI; Megrian D; Blanc H; Weger-Lucarelli J; Moratorio G; Stapleford KA; Vignuzzi M
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention.
    Vairo F; Haider N; Kock R; Ntoumi F; Ippolito G; Zumla A
    Infect Dis Clin North Am; 2019 Dec; 33(4):1003-1025. PubMed ID: 31668189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system.
    Wu J; Zhao C; Liu Q; Huang W; Wang Y
    Vaccine; 2017 Nov; 35(47):6387-6394. PubMed ID: 29031692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal Models of Chikungunya Virus Infection and Disease.
    Haese NN; Broeckel RM; Hawman DW; Heise MT; Morrison TE; Streblow DN
    J Infect Dis; 2016 Dec; 214(suppl 5):S482-S487. PubMed ID: 27920178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection.
    Abdelnabi R; Jochmans D; Verbeken E; Neyts J; Delang L
    Antiviral Res; 2018 Jan; 149():113-117. PubMed ID: 28958920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201).
    Dagley A; Ennis J; Turner JD; Rood KA; Van Wettere AJ; Gowen BB; Julander JG
    Antiviral Res; 2014 Aug; 108():1-9. PubMed ID: 24833276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection.
    Kose N; Fox JM; Sapparapu G; Bombardi R; Tennekoon RN; de Silva AD; Elbashir SM; Theisen MA; Humphris-Narayanan E; Ciaramella G; Himansu S; Diamond MS; Crowe JE
    Sci Immunol; 2019 May; 4(35):. PubMed ID: 31101672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chikungunya Arthritis: Implications of Acute and Chronic Inflammation Mechanisms on Disease Management.
    Zaid A; Gérardin P; Taylor A; Mostafavi H; Malvy D; Mahalingam S
    Arthritis Rheumatol; 2018 Apr; 70(4):484-495. PubMed ID: 29287308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and Comparison of Pathogenicity and Related Neurotropism in Two Age Groups of Immune Competent Mice, C57BL/6J Using an Indian Isolate of Chikungunya Virus (CHIKV).
    Jain J; Narayanan V; Kumar A; Shrinet J; Srivastava P; Chaturvedi S; Sunil S
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.